Abstract B057: BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors

2019 ◽  
Author(s):  
Jeffrey Clarke ◽  
Siu-Chung Chu ◽  
Lillian L Siu ◽  
Jean-Pascal Machiels ◽  
Benjamin Markman ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Clinical Activity ◽  
Advanced Solid Tumors ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug

A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2511-2511 ◽  
Author(s):  
Carlos Alberto Gomez-Roca ◽  
Valentina Boni ◽  
Victor Moreno ◽  
John Charles Morris ◽  
Jean-Pierre Delord ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug
Sign in / Sign up

Export Citation Format

Share Document